keyword
https://read.qxmd.com/read/38650795/forgoing-exchange-transfusion-in-neonatal-hyperbilirubinemia-a-single-center-retrospective-cohort-study
#1
JOURNAL ARTICLE
Nourelhouda Ouerradi, Anass Ayyad, Sahar Messaoudi, Rim Amrani
INTRODUCTION: Unconjugated hyperbilirubinemia is part of the everyday life of the neonatal period as it reflects the adaptation of the metabolism of bilirubin. The neonatal hyperbilirubinemia usually resolves spontaneously, but it can also be the cause of an acute or chronic encephalopathy known as kernicterus. Regardless of the cause, the goal of therapy is to prevent this neurotoxicity while not causing undue harm. Phototherapy and, if it is unsuccessful, exchange transfusion (ECT) remain the primary treatment modalities used to keep the maximal total serum bilirubin (TSB) below pathologic levels...
March 2024: Curēus
https://read.qxmd.com/read/38577193/strem-1-as-promising-prognostic-biomarker-for-acute-on-chronic-liver-failure-and-mortality-in-patients-with-acute-decompensation-of-cirrhosis
#2
MULTICENTER STUDY
Song-Man Yu, Hai Li, Guo-Hong Deng, Xian-Bo Wang, Xin Zheng, Jin-Jun Chen, Zhong-Ji Meng, Yu-Bao Zheng, Yan-Hang Gao, Zhi-Ping Qian, Feng Liu, Xiao-Bo Lu, Yu Shi, Jia Shang, Ruo-Chan Chen, Yan Huang
BACKGROUND: Acute decompensation (AD) of cirrhosis is associated with high short-term mortality, mainly due to the development of acute-on-chronic liver failure (ACLF). Thus, there is a need for biomarkers for early and accurate identification of AD patients with high risk of development of ACLF and mortality. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) is released from activated innate immune cells and correlated with various inflammatory processes. AIM: To explore the prognostic value of sTREM-1 in patients with AD of cirrhosis...
March 7, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38544553/effect-of-plasma-exchange-with-albumin-replacement-on-albumin-functionality-and-organ-dysfunction-in-acute-on-chronic-liver-failure
#3
JOURNAL ARTICLE
Javier Fernández, Miquel Lozano, Mireia Torres, Raquel Horrillo, Natalia Afonso, Laura Núñez, Anna Mestre, Alba Pérez, Joan Cid, Montserrat Costa, Vicente Arroyo, Antonio Páez
BACKGROUND & AIMS: Effective treatments for acute-on-chronic liver failure (ACLF) are a major unmet need. This proof-of-concept pilot study was aimed at evaluating the effects of plasma exchange (PE) with albumin 5% (PE-A5%) on albumin functional capacity and organ dysfunction in patients with ACLF. METHODS: Ten adult patients were enrolled in a single-center phase II, prospective, open-label, non-controlled study. Six PE-A5% sessions were performed in 10 days followed by a 1-month follow-up visit...
April 2024: JHEP reports: innovation in hepatology
https://read.qxmd.com/read/38514990/unconjugated-hyperbilirubinemia-in-acetaminophen-related-acute-liver-failure
#4
JOURNAL ARTICLE
Marie Philippart, Jean-Baptiste Mesland, Vincent Haufroid, Christine Collienne, Philippe Hantson
BACKGROUND In the absence of liver transplantation, the natural history of acetaminophen-induced liver failure is characterized by a progressive increase of liver function tests, including bilirubin mainly as its conjugated form. The presence of high levels of unconjugated bilirubin is more unusual; its etiology is unclear and its prognostic factor has been poorly investigated. CASE REPORT A 52-year-old man with a history of chronic analgesics, alcohol, and illicit drug abuse developed acute liver failure in relationship with the ingestion of largely supra-therapeutic doses of acetaminophen over the days preceding admission...
March 22, 2024: American Journal of Case Reports
https://read.qxmd.com/read/38409879/evaluation-of-potential-hepatic-recompensation-criteria-in-patients-with-pbc-and-decompensated-cirrhosis
#5
JOURNAL ARTICLE
Benedikt Silvester Hofer, Lukas Burghart, Emina Halilbasic, Benedikt Simbrunner, Oleksandr Petrenko, Mattias Mandorfer, Albert Friedrich Stättermayer, Michael Trauner, Thomas Reiberger
BACKGROUND: Aetiological therapy improves liver function and may enable hepatic recompensation in decompensated cirrhosis. AIMS: We explored the potential for recompensation in patients with decompensated primary biliary cholangitis (PBC) - considering a biochemical response to ursodeoxycholic acid (UDCA) according to Paris-II criteria as a surrogate for successful aetiological treatment. METHODS: Patients with PBC were retrospectively included at the time of first decompensation...
February 26, 2024: Alimentary Pharmacology & Therapeutics
https://read.qxmd.com/read/38384602/acute-on-chronic-liver-failure-causes-clinical-parameters-and-predictors-of-mortality
#6
JOURNAL ARTICLE
Fatima Hafsa, Zao Iman Chaudary, Owais Tariq, Zainab Riaz, Aamir Shehzad, Muhammad Irfan Jamil, Iqra Naeem
Objectives This study aimed to identify the causes, clinical characteristics, and 28-day in-hospital mortality predictors in patients with acute-on-chronic liver failure (ACLF). Methods A cross-sectional study enrolled sixty-four patients aged 18-70 years with acute-on-chronic liver failure. The study was conducted at the Gastroenterology Department, Lahore General Hospital. The study classified ACLF according to the criteria of the European Association for the Study of the Liver - Chronic Liver Failure (EASL-CLIF)...
January 2024: Curēus
https://read.qxmd.com/read/38283456/correlation-of-hepatic-venous-pressure-gradient-level-with-clinical-and-endoscopic-parameters-in-decompensated-chronic-liver-disease
#7
JOURNAL ARTICLE
Amol Sathawane, Harshal Khobragade, Sandip Pal
BACKGROUND: The amount of liver fibrosis usually correlates with portal pressure, which is measured as the hepatic venous pressure gradient (HVPG). The fact that portal pressure significantly decreases after treatment may increase cirrhotic patients' long-term survival suggests that measuring HVPG may offer specific information for outcome prediction. The study thus seeks to determine the relationship between the level of the HVPG and endoscopic and clinical parameters in decompensated chronic liver disease (CLD)...
December 2023: Curēus
https://read.qxmd.com/read/38216855/bilirubin-impairs-neuritogenesis-and-synaptogenesis-in-nspcs-by-downregulating-nmdar-creb-bdnf-signaling
#8
JOURNAL ARTICLE
Yan Zhang, Siyu Li, Ling Li, Hongmei Huang, Zhou Fu, Ziyu Hua
Neonatal jaundice is one of the most common disorders in the first 2 wk after birth. Unconjugated bilirubin (UCB) is neurotoxic and can cause neurological dysfunction; however, the underlying mechanisms remain unclear. Neurogenesis, neuronal growth, and synaptogenesis are exuberant in the early postnatal stage. In this study, the impact of UCB on neuritogenesis and synaptogenesis in the early postnatal stage was evaluated both in vitro and in vivo. Primary culture neuronal stem and progenitor cells (NSPCs) were treated with UCB during differentiation, and then the neurite length and synapse puncta were measured...
January 12, 2024: In Vitro Cellular & Developmental Biology. Animal
https://read.qxmd.com/read/38033855/a-zebrafish-model-for-studying-the-mechanisms-of-newborn-hyperbilirubinemia-and-bilirubin-induced-neurological-damage
#9
JOURNAL ARTICLE
Metehan Guzelkaya, Ebru Onal, Emine Gelinci, Abdullah Kumral, Gulcin Cakan-Akdogan
Unresolved neonatal hyperbilirubinemia may lead to the accumulation of excess bilirubin in the body, and bilirubin in neural tissues may induce toxicity. Bilirubin-induced neurological damage (BIND) can result in acute or chronic bilirubin encephalopathy, causing temporary or lasting neurological dysfunction or severe damage resulting in infant death. Although serum bilirubin levels are used as an indication of severity, known and unknown individual differences affect the severity of the symptoms. The mechanisms of BIND are not yet fully understood...
2023: Frontiers in Cell and Developmental Biology
https://read.qxmd.com/read/38020137/association-of-direct-bilirubin-to-total-bilirubin-ratio-with-90-day-mortality-in-patients-with-acute-on-chronic-liver-failure
#10
JOURNAL ARTICLE
Yuanji Ma, Lingyao Du, Shaoqun Zhou, Lang Bai, Hong Tang
BACKGROUND: Hyperbilirubinemia occurs when the liver fails to process bilirubin properly. A disproportionate increase in direct bilirubin indicates a decreased ability of the hepatocytes to uptake and/or convert bilirubin, which may impact the prognosis of patients with acute-on-chronic liver failure (ACLF). However, the association of direct bilirubin to total bilirubin ratio (DB/TB) with outcomes in patients with ACLF remains unclear. METHODS: A retrospective study was conducted in West China Hospital of Sichuan University to assess the association between DB/TB and 90-day mortality in patients with ACLF...
2023: Frontiers in Medicine
https://read.qxmd.com/read/37789170/clinical-long-term-outcome-of-hepatitis-d-compared-to-hepatitis-b-monoinfection
#11
JOURNAL ARTICLE
Anika Wranke, Benjamin Heidrich, Katja Deterding, Katharina Luise Hupa-Breier, Janina Kirschner, Birgit Bremer, Markus Cornberg, Heiner Wedemeyer
BACKGROUND AND AIMS: Hepatitis D virus (HDV) infection causes the most severe form of chronic viral hepatitis. However, it is still unclear to what extent the underlying cirrhosis may contribute to disease progression. The aim of this study was to compare the long-term outcome of HDV infection with HBV monoinfection in a single-center cohort of both non-cirrhotic and cirrhotic patients. METHOD: We retrospectively studied 175 patients with chronic hepatitis D (CHD) who were followed for at least 6 months (median of 6...
October 3, 2023: Hepatology International
https://read.qxmd.com/read/37771877/role-of-the-phase-angle-in-the-prognosis-of-the-cirrhotic-patient-15-years-of-follow-up
#12
JOURNAL ARTICLE
Letícia Pereira Pinto, Claudio Augusto Marroni, Juliana Czermainski, Maria Luiza Fernandes Dahlem, Randhall B Carteri, Sabrina Alves Fernandes
BACKGROUND: In 2019, cirrhosis accounted for 2.4% of global deaths. The projection for 2030 is an increase in this index. In recent years, hospitalization costs have escalated by 36% for compensated cirrhosis and 24% for decompensated cirrhosis. Therefore, it is necessary to identify a tool capable of predicting the mortality of these patients according to their clinical condition and consequently extending their survival time. Different studies have shown that the phase angle (PA) can be a feasible method in clinical practice, with the potential to guide assertive patient management in the therapeutic of chronic liver disease...
September 20, 2023: World Journal of Methodology
https://read.qxmd.com/read/37690912/second-nationwide-survey-of-bilirubin-encephalopathy-in-preterm-infants-in-japan
#13
JOURNAL ARTICLE
Akihisa Okumura, Ichiro Morioka, Hiroshi Arai, Masahiro Hayakawa, Yoshihiro Maruo, Takashi Kusaka, Tetsuya Kunikata, Sota Iwatani
OBJECTIVES: To determine the clinical features of bilirubin encephalopathy in preterm infants (pBE) in Japan. METHODS: We performed a retrospective, nationwide questionnaire-based survey. The initial survey determined the number of children with pBE who were born after 2000. Using a structured questionnaire, the second survey clarified the clinical manifestations and characteristics of children with pBE, including demographic data, neurological symptoms, and MRI and auditory brainstem response (ABR) findings...
September 8, 2023: Brain & Development
https://read.qxmd.com/read/37689475/older-adult-woman-in-a-coma-after-acute-laryngitis
#14
Alexander Landerl, Irina Covaliova, Christoph Camille Ganter, Stefano Mancini, Sascha David, Rea Andermatt
A 72-year-old woman with a history of adenocarcinoma of the lung, for which she was receiving tyrosine kinase inhibitor therapy with osimertinib, was admitted to the ED because of clinical deterioration with extreme fatigue and fever. She was already receiving antibiotic therapy initiated by her general practitioner because of symptoms of an upper respiratory tract infection. She was febrile (38.5 °C) with normal laboratory values except for leukocytosis and elevated C-reactive protein. She was hospitalized because of profound general malaise...
September 2023: Chest
https://read.qxmd.com/read/37510935/hematological-indices-are-useful-in-predicting-complications-of-liver-cirrhosis
#15
JOURNAL ARTICLE
Tijana Glisic, Dusan D Popovic, Iva Lolic, Aleksandar Toplicanin, Katarina Jankovic, Sanja Dragasevic, Marko Aleksic, Mihailo Stjepanovic, Branislav Oluic, Vera Matovic Zaric, Mirjana M Radisavljevic, Milica Stojkovic Lalosevic
BACKGROUND: Liver cirrhosis is the final stage of chronic liver disease. We aimed to evaluate non-invasive scores as predictors of complications and outcome in cirrhotic patients. METHODS: A total of 150 cirrhotic patients were included. Models for end-stage liver disease (MELD), albumin-bilirubin (ALBI) score, neutrophil-lymphocyte ratio (NLR), monocyte-lymphocyte ratio (MoLR), and neutrophil-lymphocyte-albumin ratio (NLA) scores were tested in relation to the development of complications and mortality using receiver operating characteristic (ROC) curves...
July 21, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/37395245/antithrombin-iii-activity-is-associated-with-prognosis-infection-and-inflammation-in-patients-with-hepatitis-b-virus-related-acute-on-chronic-liver-failure
#16
JOURNAL ARTICLE
Xueshi Zhou, Xinyue Chen, Hejuan Du, Yangqun Ye, Youhan Miu, Tingting Su, Xiaoye Guo, Sen Wang, Yuanwang Qiu, Jun Wang, Weifeng Zhao
OBJECTIVE: Patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) are characterized by severe liver function impairment, coagulation disorder, and multiple organ function impairment. The aim of this study was to explore the predictive value of antithrombin Ⅲ activity to the prognosis of HBV-ACLF patients. METHODS: A total of 186 HBV-ACLF patients were included in the analysis, and the baseline clinical data of patients were recorded to analyze the risk factors affecting the 30-day survival outcome of patients...
August 1, 2023: European Journal of Gastroenterology & Hepatology
https://read.qxmd.com/read/37386640/relapsed-nodular-lymphocyte-predominant-hodgkin-lymphoma-presenting-as-severe-paraneoplastic-hepatitis-a-case-report
#17
JOURNAL ARTICLE
Anthony J Deacon, Naeman N Goetz, Nicholas Weber, Andrew Clouston, Enoka Gonsalkorala, Catherine Baskerville, Barbara Leggett
BACKGROUND: Hematological malignancies are an infrequent but important cause of liver dysfunction. There are several mechanisms by which this can occur, including direct malignant infiltration of the hepatic parenchyma and/or vasculature, vanishing bile duct syndrome, and paraneoplastic hepatitis. Paraneoplastic hepatitis is an extremely rare mechanism by which a hematological malignancy can cause liver dysfunction, and we present the first case, to our knowledge, of paraneoplastic hepatitis caused by nodular lymphocyte-predominant Hodgkin lymphoma in the literature...
June 30, 2023: Journal of Medical Case Reports
https://read.qxmd.com/read/37371422/effect-of-berberine-against-cognitive-deficits-in-rat-model-of-thioacetamide-induced-liver-cirrhosis-and-hepatic-encephalopathy-behavioral-biochemical-molecular-and-histological-evaluations
#18
JOURNAL ARTICLE
Somayeh Hajipour, Yaghoob Farbood, Mahin Dianat, Ali Nesari, Alireza Sarkaki
BACKGROUND: Liver cirrhosis (LC) is one of the chronic liver diseases with high disability and mortality accompanying hepatic encephalopathy (HE) followed by cognitive dysfunctions. In this work, the effect of berberine (Ber) on spatial cognition was studied in a rat model of LC induced by thioacetamide (TAA). MATERIALS AND METHODS: Male Wistar rats (200-250 g) were divided into six groups: (1) control; (2) TAA, 200 mg/kg/day, i.p.; (3-5) TAA + Ber; received Ber (10, 30, and 60 mg/kg, i...
June 12, 2023: Brain Sciences
https://read.qxmd.com/read/37225491/serum-zinc-%C3%AE-2-glycoprotein-levels-are-associated-with-the-hepatorenal-function-and-predict-the-survival-in-cases-of-chronic-liver-disease
#19
JOURNAL ARTICLE
Ryuta Shigefuku, Motoh Iwasa, Akiko Eguchi, Mina Tempaku, Yasuyuki Tamai, Naoto Fujiwara, Ryosuke Sugimoto, Hideaki Tanaka, Kazushi Sugimoto, Yoshinao Kobayashi, Hayato Nakagawa
Background Zinc-α2-glycoprotein (ZAG) is secreted by various organs, such as liver, kidney and adipose tissue; is involved in lipolysis; and may contribute to the pathogenesis of chronic liver disease (CLD). We therefore assessed whether or not ZAG is a surrogate marker for the hepatorenal function, body composition and all causes of mortality, as well as complications, including ascites, hepatic encephalopathy (HE) and portosystemic shunts (PSS) in CLD. Methods Serum ZAG levels were measured in 180 CLD patients upon hospital admission...
May 24, 2023: Internal Medicine
https://read.qxmd.com/read/37208098/should-patients-with-acute-on-chronic-liver-failure-grade-3-receive-higher-priority-for-liver-transplantation
#20
REVIEW
Florent Artru, David Goldberg, Patrick S Kamath
In this debate, the authors consider whether patients with acute-on-chronic liver failure grade 3 (ACLF-3) should receive higher liver transplant priority, with reference to the following clinical case: a 62-year-old male with a history of decompensated alcohol-associated cirrhosis, with recurrent ascites and hepatic encephalopathy, and metabolic comorbidities (type 2 diabetes mellitus, arterial hypertension and a BMI of 31 kg/m2 ). A few days following evaluation for liver transplantation (LT), the patient was admitted to the intensive care unit and placed on mechanical ventilation for neurological failure, FiO2 of 0...
June 2023: Journal of Hepatology
keyword
keyword
91207
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.